Key points are not available for this paper at this time.
These findings validate a new disease-specific quality-of-life instrument for patients with cervicofacial nonmelanoma skin cancer. Studies on the responsiveness of the Skin Cancer Index to clinical intervention are currently under way.
Rhee et al. (Fri,) studied this question.